⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for pf 01367338

Every month we try and update this database with for pf 01367338 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study of Rucaparib in Patients With Pancreatic Cancer and a Known Deleterious BRCA MutationNCT02042378
Pancreatic Canc...
Pancreatic Duct...
Rucaparib
18 Years - pharmaand GmbH
Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer (ARIEL3)NCT01968213
Ovarian Cancer
Fallopian Tube ...
Peritoneal Canc...
Rucaparib
Placebo
18 Years - pharmaand GmbH
A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)NCT01891344
Ovarian Cancer
Epithelial Ovar...
Fallopian Tube ...
Peritoneal Canc...
Oral rucaparib
18 Years - pharmaand GmbH
A Study of Oral Rucaparib in Patients With a Solid Tumor (Phase I) or With gBRCA Mutation Ovarian Cancer (Phase II)NCT01482715
Ovarian Cancer
Fallopian Tube ...
Peritoneal Canc...
Advanced Solid ...
Rucaparib
18 Years - pharmaand GmbH
A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)NCT01891344
Ovarian Cancer
Epithelial Ovar...
Fallopian Tube ...
Peritoneal Canc...
Oral rucaparib
18 Years - pharmaand GmbH
ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer PatientsNCT02855944
Ovarian Cancer
Epithelial Ovar...
Fallopian Tube ...
Peritoneal Canc...
Chemotherapy
Rucaparib
18 Years - pharmaand GmbH
ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer PatientsNCT02855944
Ovarian Cancer
Epithelial Ovar...
Fallopian Tube ...
Peritoneal Canc...
Chemotherapy
Rucaparib
18 Years - pharmaand GmbH
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: